1. Home
  2. HOWL vs MLSS Comparison

HOWL vs MLSS Comparison

Compare HOWL & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Werewolf Therapeutics Inc.

HOWL

Werewolf Therapeutics Inc.

HOLD

Current Price

$0.96

Market Cap

48.1M

Sector

Health Care

ML Signal

HOLD

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.47

Market Cap

42.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOWL
MLSS
Founded
2017
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.1M
42.6M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
HOWL
MLSS
Price
$0.96
$0.47
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$5.00
$1.00
AVG Volume (30 Days)
10.4M
158.0K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
18.40
N/A
EPS
N/A
N/A
Revenue
N/A
$8,973,982.00
Revenue This Year
N/A
$12.64
Revenue Next Year
N/A
$8.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.99
52 Week Low
$0.27
$0.22
52 Week High
$2.23
$0.64

Technical Indicators

Market Signals
Indicator
HOWL
MLSS
Relative Strength Index (RSI) 82.17 50.73
Support Level $0.80 $0.24
Resistance Level $1.17 $0.48
Average True Range (ATR) 0.07 0.03
MACD 0.04 -0.01
Stochastic Oscillator 89.45 31.90

Price Performance

Historical Comparison
HOWL
MLSS

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer and other immune-mediated conditions. It is leveraging the proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. It has one reportable segment, which focuses on the discovery and development of cancer therapeutics.

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

Share on Social Networks: